Use of hydroxyethyl starch in sepsis research: A systematic review with meta-analysis

被引:3
|
作者
Johansen, Jes R. [1 ]
Perner, Anders [1 ]
Brodtkorb, Julie H. [1 ]
Moller, Morten H. [1 ]
机构
[1] Univ Copenhagen, Rigshosp, Dept Intens Care, Copenhagen, Denmark
关键词
adverse effects; hydroxyethyl starch (HES) 130/0.38-0.45; sepsis; RESUSCITATION; 6-PERCENT; MANAGEMENT; OUTCOMES; SALINE;
D O I
10.1111/aas.13954
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: After being used for more than a decade the use of hydroxyethyl starch (HES) 130/0.38-0.45 in clinical practice was discouraged because of serious adverse events including bleeding, acute kidney injury and death. But could these adverse effects have been discovered sooner? By comparing the summary effect estimates of the adverse effects of HES 130/0.38-0.45 in different study designs we aimed to disclose any signal of this. Methods: We systematically searched MEDLINE, EMBASE and Cochrane Library and hand-searched the reference lists of relevant studies to identify studies for inclusion. Eligible trials were randomised clinical trials (RCTs) and observational studies in patients with sepsis and randomised trials in animals with induced sepsis comparing HES 130/0.38-0.45 to any type of crystalloid. Relevant outcomes were all-cause mortality at longest follow-up, renal replacement therapy (RRT), acute kidney injury (AKI) and bleeding. We extracted data, conducted conventional meta-analyses and assessed the risk of bias and the quality of evidence. Results: We included 8 RCTs including 3,273 patients, 1 observational study including 379 patients and 5 randomised animal trials including 94 test animals. There was no suggestion of interaction in subgroup analyses comparing the different study designs for any outcomes (all-cause mortality at longest follow-up p = .33; RRT p = .70; AKI p = .63; bleeding p = .20). Conclusions: We observed no interaction between the summary effect estimates of RCTs, observational studies in patients and randomised animal trials for any of the outcomes. Accordingly, we found no evidence indicating that the adverse effects of HES 130/0.38-0.45 could have been discovered sooner. Systematic review registration: PROSPERO ID: CRD42018103422. Protocol Johansen JR, Perner A, Brodtkorb JH, Moller MH. Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review. Acta Anaesthesiol Scand. 2019;63:814-818.
引用
收藏
页码:1355 / 1364
页数:10
相关论文
共 50 条
  • [1] Use of hydroxyethyl starch in sepsis research: Protocol for a systematic review
    Johansen, Jes R.
    Perner, Anders
    Brodtkorb, Julie H.
    Moller, Morten H.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2019, 63 (06) : 814 - 818
  • [2] Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis
    Rochwerg, B.
    Alhazzani, W.
    Gibson, A.
    Ribic, C. M.
    Sindi, A.
    Heels-Ansdell, D.
    Thabane, L.
    Fox-Robichaud, A.
    Mbuagbaw, L.
    Szczeklik, W.
    Alshamsi, F.
    Altayyar, S.
    Ip, W.
    Li, G.
    Wang, M.
    Wludarczyk, A.
    Zhou, Q.
    Annane, D.
    Cook, D. J.
    Jaeschke, R.
    Guyatt, G. H.
    INTENSIVE CARE MEDICINE, 2015, 41 (09) : 1561 - 1571
  • [3] The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis
    Delaney, Anthony P.
    Dan, Arina
    McCaffrey, John
    Finfer, Simon
    CRITICAL CARE MEDICINE, 2011, 39 (02) : 386 - 391
  • [4] Early fluid bolus in adults with sepsis in the emergency department: a systematic review, meta-analysis and narrative synthesis
    Kabil, Gladis
    Frost, Steven A.
    Hatcher, Deborah
    Shetty, Amith
    Foster, Jann
    McNally, Stephen
    BMC EMERGENCY MEDICINE, 2022, 22 (01)
  • [5] Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis
    B. Rochwerg
    W. Alhazzani
    A Gibson
    C. M. Ribic
    A. Sindi
    D. Heels-Ansdell
    L. Thabane
    A. Fox-Robichaud
    L. Mbuagbaw
    W. Szczeklik
    F. Alshamsi
    S. Altayyar
    W. Ip
    G. Li
    M. Wang
    A. Włudarczyk
    Q. Zhou
    D. Annane
    D. J. Cook
    R. Jaeschke
    G. H. Guyatt
    Intensive Care Medicine, 2015, 41 : 1561 - 1571
  • [6] Use of melatonin as adjunctive therapy in neonatal sepsis: A systematic review and meta-analysis
    Henderson, Renesha
    Kim, Seungyeon
    Lee, Euni
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 39 : 131 - 136
  • [7] Association between fluid overload and mortality in children with sepsis: a systematic review and meta-analysis
    Fernandez-Sarmiento, Jaime
    Sierra-Zuniga, Marco Fidel
    Gonzalez, Maria Paula Salazar
    Lucena, Natalia
    Soares Lanziotti, Vanessa
    Agudelo, Sergio
    BMJ PAEDIATRICS OPEN, 2023, 7 (01)
  • [8] Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
    Rochwerg, Bram
    Oczkowski, Simon J.
    Siemieniuk, Reed A. C.
    Agoritsas, Thomas
    Belley-Cote, Emilie
    D'Aragon, Frederick
    Duan, Erick
    English, Shane
    Gossack-Keenan, Kira
    Alghuroba, Mashari
    Szczeklik, Wojciech
    Menon, Kusum
    Alhazzani, Waleed
    Sevransky, Jonathan
    Vandvik, Per Olav
    Annane, Djillali
    Guyatt, Gordon
    CRITICAL CARE MEDICINE, 2018, 46 (09) : 1411 - 1420
  • [9] Immunomodulatory drugs in sepsis: a systematic review and meta-analysis
    Robey, R. C.
    Logue, C.
    Caird, C. A.
    Hansel, J.
    Hellyer, T. P.
    Simpson, J.
    Dark, P.
    Mathioudakis, A. G.
    Felton, T.
    ANAESTHESIA, 2024, 79 (08) : 869 - 879
  • [10] Digital Alerting and Outcomes in Patients With Sepsis: Systematic Review and Meta-Analysis
    Joshi, Meera
    Ashrafian, Hutan
    Arora, Sonal
    Khan, Sadia
    Cooke, Graham
    Darzi, Ara
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2019, 21 (12)